When implemented by an experienced team, remote monitoring of patients with heart failure and implanted devices reduces both hospitalizations and outpatient clinic visits, the single-center RESULT trial shows.
Visit WebsiteThere has been a marked reduction in the number of patients hospitalized for acute myocardial infarction, as well as significant improvements in short- and midterm clinical outcomes, over the past 20 years, according to a new analysis of Medicare fee-for-service patients.
Visit WebsitePeople using high-dose nifedipine (60 mg/day or more) appear to carry a greater risk of out-of-hospital cardiac arrest compared with those who are not taking a dihydropyridine for hypertension or angina, a registry study shows.
Visit WebsiteThe use of 18F-fluoride positron emission tomography (PET)-computed tomography (CT) appears to be a more sensitive test than conventional assessments for the detection of subclinical valve degeneration following bioprosthetic aortic valve replacement, according to the results of a new study.
Visit WebsitePatients with mitral stenosis and A-fib appear to do better when they receive direct oral anticoagulants (DOACs) instead of warfarin, an observational analysis suggests. The data, while not randomized, offer insight into an important patient group, one which was largely excluded from the trials that first brought DOACs to market, experts say.
Visit WebsiteOne-year data from an investigator-initiated study of TAVR in aortic stenosis patients at low surgical risk continues to show good safety, according to new findings from the LRT trial presented here.
Visit WebsiteAn analysis looking at adverse events related to use of two different guide extension catheters reported to the US Food and Drug Administration should spur operators to use these devices with caution, experts say
Visit WebsiteIf the stars align, the full results of the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial should be published and presented late this year, but a new publication will give those eagerly anticipating the results something to chew on for the time being.
Visit WebsiteA large analysis of Medicare patients shows no difference in long-term mortality between those who received a paclitaxel-eluting stent or BMS for the treatment of femoropopliteal artery disease.
Visit Website